Order byBest matchMost fresh

FDA, COVID and vaccine

Digest more
FDA tightens requirements for COVID vaccine, adding trials for healthy adults
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to older adults and those at risk of developing severe illness.

Continue reading

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
FDA offers new guidelines to shift COVID vaccine focus to high-risk groups
US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant
The U.S. Senate plans to vote this week to bar California's landmark plan to end the sale of gasoline-only vehicles by 2035 that has been adopted by 11 other states, Majority Leader John Thune said on...

Continue reading

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved
US regulators say annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved
FDA plans to limit COVID vaccine to only high-risk people. Florida cases, deaths in 2025
Public trust in vaccination has declined, potentially impacting other vital immunization programs.

Continue reading

New FDA rule could delay Covid vaccine rollout for healthy adults and kids
F.D.A. Poised to Restrict Access to Covid Vaccines
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 infection.
FDA sets new COVID booster guidelines for healthy adults under 65
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Explore more
Feedback